Correlation Between Assembly Biosciences and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Terns Pharmaceuticals, you can compare the effects of market volatilities on Assembly Biosciences and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Terns Pharmaceuticals.
Diversification Opportunities for Assembly Biosciences and Terns Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Assembly and Terns is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Assembly Biosciences and Terns Pharmaceuticals
Given the investment horizon of 90 days Assembly Biosciences is expected to generate 0.8 times more return on investment than Terns Pharmaceuticals. However, Assembly Biosciences is 1.25 times less risky than Terns Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 1,674 in Assembly Biosciences on August 28, 2024 and sell it today you would lose (154.00) from holding Assembly Biosciences or give up 9.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.44% |
| Values | Daily Returns |
Assembly Biosciences vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Assembly Biosciences |
| Terns Pharmaceuticals |
Assembly Biosciences and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assembly Biosciences and Terns Pharmaceuticals
The main advantage of trading using opposite Assembly Biosciences and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Assembly Biosciences vs. Eliem Therapeutics | Assembly Biosciences vs. Scpharmaceuticals | Assembly Biosciences vs. Milestone Pharmaceuticals | Assembly Biosciences vs. Seres Therapeutics |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |